You just read:

OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment

News provided by

OncoGenex Pharmaceuticals, Inc.

Apr 30, 2013, 08:00 ET